Rapamycin is an mTOR inhibitor with immune-suppressor activities, which directly inhibits tumor cell proliferation by arresting the cell cycle, and angiogenesis through a decrease in the production of VEGF [17]. The gene discussed is VEGFA; the disease is neoplasm.